|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/14 | |
| C12N 9/10 | |||
| C12P 21/00 | |||
| C12Q 1/48 | |||
| C07K 16/00 |
| (11) | Patento numeris | 2991666 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14792116.7 |
| Europos patento paraiškos padavimo data | 2014-05-01 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-03-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-03-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/036413 |
| Data | 2014-05-01 |
| (87) | Numeris | WO 2014/179601 |
| Data | 2014-11-06 |
| (30) | Numeris | Data | Šalis |
| 201361818563 P | 2013-05-02 | US |
| (72) |
BHATNAGAR, Naveen, US
MECCARIELLO, Robin, US
LANSING, Jonathan, C., US
ORTIZ, Daniel, US
SARVAIYA, Hetal, US
WASHBURN, Nathaniel, US
|
| (73) |
Momenta Pharmaceuticals, Inc.,
301 Binney Street, Cambridge, MA 02142,
US
|
| (54) | SIALYLATED GLYCOPROTEINS |
| SIALYLATED GLYCOPROTEINS |